Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Benn

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 17, 2024
Evaluating reproductive carrier screening using biotinidase deficiency as a model: Variants identified, variant rates, and managementPeter Benn, Yang Wang, Josie Gray, et al.
Journal of Clinical Medicine|August 29, 2019
Quality Assurance of Non-Invasive Prenatal Screening (NIPS) for Fetal Aneuploidy Using Positive Predictive Values as Outcome MeasuresWendy DiNonno, Zachary Demko, Kimberly Martin, et al.
American Journal of Obstetrics and Gynecology|May 27, 2009
Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialistsYu Ming Victor Fang, Peter Benn, Winston Campbell, et al.
Prenatal Diagnosis|September 26, 2012
Optimal cut-offs for Down syndrome contingent screening in a population of 10,156 pregnant womenPaolo Guanciali-Franchi, Irene Iezzi, Alessandra Soranno, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|August 13, 2019
Non-invasive prenatal screening: A 20-year experience in ItalyChiara Palka, Paolo Guanciali-Franchi, Elisena Morizio, et al.
Plos One|December 8, 2017
Sequential combined test, second trimester maternal serum markers, and circulating fetal cells to select women for invasive prenatal diagnosisPaolo Guanciali Franchi, Chiara Palka, Elisena Morizio, et al.
Prenatal Diagnosis|November 14, 2013
Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testingPeter Benn, Audrey R Chapman, Kristine Erickson, et al.
Molecular Genetics & Genomic Medicine|November 30, 2016
Aneuploidy screening using circulating fetal cells in maternal blood by dual-probe FISH protocol: a prospective feasibility study on a series of 172 pregnant womenGiuseppe Calabrese, Donatella Fantasia, Melissa Alfonsi, et al.
Obstetrics and Gynecology|August 10, 2023
Reproductive Carrier Screening Results With Maternal Health Implications During PregnancyVivienne Souter, Brittany Prigmore, Emily Becraft, et al.
Molecular Genetics & Genomic Medicine|November 28, 2017
Pediatric healthcare costs for patients with 22q11.2 deletion syndromePeter Benn, Sushma Iyengar, Terrence Blaine Crowley, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 17, 2024
Evaluating reproductive carrier screening using biotinidase deficiency as a model: Variants identified, variant rates, and managementPeter Benn, Yang Wang, Josie Gray, et al.
Journal of Clinical Medicine|August 29, 2019
Quality Assurance of Non-Invasive Prenatal Screening (NIPS) for Fetal Aneuploidy Using Positive Predictive Values as Outcome MeasuresWendy DiNonno, Zachary Demko, Kimberly Martin, et al.
American Journal of Obstetrics and Gynecology|May 27, 2009
Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialistsYu Ming Victor Fang, Peter Benn, Winston Campbell, et al.
Prenatal Diagnosis|September 26, 2012
Optimal cut-offs for Down syndrome contingent screening in a population of 10,156 pregnant womenPaolo Guanciali-Franchi, Irene Iezzi, Alessandra Soranno, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|August 13, 2019
Non-invasive prenatal screening: A 20-year experience in ItalyChiara Palka, Paolo Guanciali-Franchi, Elisena Morizio, et al.
Plos One|December 8, 2017
Sequential combined test, second trimester maternal serum markers, and circulating fetal cells to select women for invasive prenatal diagnosisPaolo Guanciali Franchi, Chiara Palka, Elisena Morizio, et al.
Prenatal Diagnosis|November 14, 2013
Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testingPeter Benn, Audrey R Chapman, Kristine Erickson, et al.
Molecular Genetics & Genomic Medicine|November 30, 2016
Aneuploidy screening using circulating fetal cells in maternal blood by dual-probe FISH protocol: a prospective feasibility study on a series of 172 pregnant womenGiuseppe Calabrese, Donatella Fantasia, Melissa Alfonsi, et al.
Obstetrics and Gynecology|August 10, 2023
Reproductive Carrier Screening Results With Maternal Health Implications During PregnancyVivienne Souter, Brittany Prigmore, Emily Becraft, et al.
Molecular Genetics & Genomic Medicine|November 28, 2017
Pediatric healthcare costs for patients with 22q11.2 deletion syndromePeter Benn, Sushma Iyengar, Terrence Blaine Crowley, et al.
Pageof 9